BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31911830)

  • 1. Epidemiology of Carbapenem-resistant Enterobacteriaceae in Egyptian intensive care units using National Healthcare-associated Infections Surveillance Data, 2011-2017.
    Kotb S; Lyman M; Ismail G; Abd El Fattah M; Girgis SA; Etman A; Hafez S; El-Kholy J; Zaki MES; Rashed HG; Khalil GM; Sayyouh O; Talaat M
    Antimicrob Resist Infect Control; 2020; 9(1):2. PubMed ID: 31911830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of colonisation with carbapenem-resistant Enterobacteriaceae among patients admitted to Vietnamese hospitals: Risk factors and burden of disease.
    Tran DM; Larsson M; Olson L; Hoang NTB; Le NK; Khu DTK; Nguyen HD; Vu TV; Trinh TH; Le TQ; Phan PTT; Nguyen BG; Pham NH; Mai BH; Nguyen TV; Nguyen PTK; Le ND; Huynh TM; Anh Thu LT; Thanh TC; Berglund B; Nilsson LE; Bornefall E; Song LH; Hanberger H
    J Infect; 2019 Aug; 79(2):115-122. PubMed ID: 31125639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018.
    Perovic O; Ismail H; Quan V; Bamford C; Nana T; Chibabhai V; Bhola P; Ramjathan P; Swe Swe-Han K; Wadula J; Whitelaw A; Smith M; Mbelle N; Singh-Moodley A;
    Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1287-1294. PubMed ID: 32124106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Molecular Epidemiology of Carbapenem-Resistant Enterobacteriaceae Among Adult Inpatients in Singapore.
    Marimuthu K; Venkatachalam I; Khong WX; Koh TH; Cherng BPZ; Van La M; De PP; Krishnan PU; Tan TY; Choon RFK; Pada SK; Lam CW; Ooi ST; Deepak RN; Smitasin N; Tan EL; Lee JJ; Kurup A; Young B; Sim NTW; Thoon KC; Fisher D; Ling ML; Peng BAS; Teo YY; Hsu LY; Lin RTP; Ong RT; Teo J; Ng OT;
    Clin Infect Dis; 2017 May; 64(suppl_2):S68-S75. PubMed ID: 28475792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vital signs: carbapenem-resistant Enterobacteriaceae.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Mar; 62(9):165-70. PubMed ID: 23466435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013.
    Guh AY; Bulens SN; Mu Y; Jacob JT; Reno J; Scott J; Wilson LE; Vaeth E; Lynfield R; Shaw KM; Vagnone PM; Bamberg WM; Janelle SJ; Dumyati G; Concannon C; Beldavs Z; Cunningham M; Cassidy PM; Phipps EC; Kenslow N; Travis T; Lonsway D; Rasheed JK; Limbago BM; Kallen AJ
    JAMA; 2015 Oct; 314(14):1479-87. PubMed ID: 26436831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Admission screening and cohort care decrease carbapenem resistant enterobacteriaceae in Vietnamese pediatric ICU's.
    Garpvall K; Duong V; Linnros S; Quốc TN; Mucchiano D; Modeen S; Lagercrantz L; Edman A; Le NK; Huong T; Hoang NTB; Le HT; Khu DT; Tran DM; Phuc PH; Hanberger H; Olson L; Larsson M
    Antimicrob Resist Infect Control; 2021 Aug; 10(1):128. PubMed ID: 34462014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and risk factors of carbapenem-resistant
    Aleidan FAS; Alkhelaifi H; Alsenaid A; Alromaizan H; Alsalham F; Almutairi A; Alsulaiman K; Abdel Gadir AG
    Expert Rev Anti Infect Ther; 2021 Mar; 19(3):393-398. PubMed ID: 32930620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection control and risk factors for acquisition of carbapenemase-producing enterobacteriaceae. A 5 year (2011-2016) case-control study.
    Segagni Lusignani L; Presterl E; Zatorska B; Van den Nest M; Diab-Elschahawi M
    Antimicrob Resist Infect Control; 2020; 9(1):18. PubMed ID: 31988746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors and Molecular Epidemiology of Complicated Intra-Abdominal Infections With Carbapenem-Resistant Enterobacteriaceae: A Multicenter Study in China.
    Liu J; Zhang L; Pan J; Huang M; Li Y; Zhang H; Wang R; Zhao M; Li B; Liu L; Gong Y; Bian J; Li X; Tang Y; Lei M; Chen D
    J Infect Dis; 2020 Mar; 221(Suppl 2):S156-S163. PubMed ID: 32176797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of carbapenem-resistant Enterobacteriaceae in hospitals of a large healthcare system in Miami, Florida from 2012 to 2016: Five years of experience with an internal registry.
    Jimenez A; Trepka MJ; Munoz-Price LS; Pekovic V; Ibrahimou B; Abbo LM; Martinez O; Sposato K; dePascale D; Perez-Cardona A; McElheny CL; Bachman WC; Fowler EL; Doi Y; Fennie K
    Am J Infect Control; 2020 Nov; 48(11):1341-1347. PubMed ID: 32334004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and risk factors for carbapenem-resistant Enterobacteriaceae colonisation and infections: case-controlled study from an academic medical center in a southern area of China.
    Fang L; Lu X; Xu H; Ma X; Chen Y; Liu Y; Hong G; Liang X
    Pathog Dis; 2019 Jun; 77(4):. PubMed ID: 31281931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and predictors of health care-associated infections among patients colonized with carbapenem-resistant Enterobacteriaceae.
    Correa AAF; Fortaleza CMCB
    Am J Infect Control; 2019 Feb; 47(2):213-216. PubMed ID: 30279017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Risk Factors of Carbapenem-resistant
    Kang JS; Yi J; Ko MK; Lee SO; Lee JE; Kim KH
    J Korean Med Sci; 2019 May; 34(18):e140. PubMed ID: 31074254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Risk for Carbapenem-Resistant Enterobacteriaceae Colonization in Intensive Care Units after Hospitalization in Emergency Department.
    Salomão MC; Freire MP; Boszczowski I; Raymundo SF; Guedes AR; Levin AS
    Emerg Infect Dis; 2020 Jun; 26(6):1156-1163. PubMed ID: 32267827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of infections due to third generation cephalosporin-resistant
    Rohde AM; Zweigner J; Wiese-Posselt M; Schwab F; Behnke M; Kola A; Obermann B; Knobloch JK; Feihl S; Querbach C; Gebhardt F; Mischnik A; Ihle V; Schröder W; Armean S; Peter S; Tacconelli E; Hamprecht A; Seifert H; Vehreschild MJGT; Kern WV; Gastmeier P;
    Antimicrob Resist Infect Control; 2018; 7():159. PubMed ID: 30603083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal carriage of carbapenem-resistant
    Mohan B; Prasad A; Kaur H; Hallur V; Gautam N; Taneja N
    Indian J Med Microbiol; 2017; 35(4):555-562. PubMed ID: 29405149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012.
    Logan LK; Renschler JP; Gandra S; Weinstein RA; Laxminarayan R; ;
    Emerg Infect Dis; 2015 Nov; 21(11):2014-21. PubMed ID: 26486124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand.
    Netikul T; Kiratisin P
    PLoS One; 2015; 10(9):e0139116. PubMed ID: 26407326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.